// App-Quantinova.ai

86 : A longitudinal analysis of prevalence of sustained remission and low disease activity in rheumatoid arthritis patients treated with anti-tumour necrosis factor: an analysis of the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Researchers

Presenter

  • Philip D H Hamann

Principal Investigators

  • Gavin Shaddick

  • Neil McHugh

  • Kimme Hyrich

  • John D Pauling

Medical Centers

  • Department of Pharmacy and Pharmacology, University of Bath, Bath, UNITED KINGDOM

  • College of Engineering, Mathematics and Physical Sciences, University of Exeter, Exeter, UNITED KINGDOM

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A